Abstract
Quantitative structure-activity relationships (QSAR) analyses have been attempted on a new set of 4- oxothiazolidines and 5-arylidines derivatives using linear free energy related (LFER) model of Hansch to explain the structural requirements for lipoxygenase inhibition. The QSAR study showed that successful correlation can be achieved for inhibitory activity of 4-oxothiazolidines and 5-arylidines (R > 0.9, Q2 > 0.7). The result of the QSAR study suggests the bulky substituents in the thiazolidine nucleus will decrease the binding affinity of 4-oxothiazolidines derivatives towards lipoxygenase indicated by negative contribution of molar refractivity and connolly accessible area. The positive contribution of topological parameters (BI, MTI, CC and TVC) illustrates that increase in branching and presence of heteroatom are favorable for lipoxygenase inhibitory activity.
Keywords: Quantitative structure-activity relationship, QSAR, lipoxygenase inhibitors, anti-inflammatory, substituted 4-oxathiazolidines, 5-arylidines
Mini-Reviews in Medicinal Chemistry
Title: Quantitative Structure Activity Relationship (QSAR) Analysis of Substituted 4-Oxothiazolidines and 5-Arylidines as Lipoxygenase Inhibitors
Volume: 10 Issue: 8
Author(s): A.N. Choudhary, A. Kumar and V. Juyal
Affiliation:
Keywords: Quantitative structure-activity relationship, QSAR, lipoxygenase inhibitors, anti-inflammatory, substituted 4-oxathiazolidines, 5-arylidines
Abstract: Quantitative structure-activity relationships (QSAR) analyses have been attempted on a new set of 4- oxothiazolidines and 5-arylidines derivatives using linear free energy related (LFER) model of Hansch to explain the structural requirements for lipoxygenase inhibition. The QSAR study showed that successful correlation can be achieved for inhibitory activity of 4-oxothiazolidines and 5-arylidines (R > 0.9, Q2 > 0.7). The result of the QSAR study suggests the bulky substituents in the thiazolidine nucleus will decrease the binding affinity of 4-oxothiazolidines derivatives towards lipoxygenase indicated by negative contribution of molar refractivity and connolly accessible area. The positive contribution of topological parameters (BI, MTI, CC and TVC) illustrates that increase in branching and presence of heteroatom are favorable for lipoxygenase inhibitory activity.
Export Options
About this article
Cite this article as:
Choudhary A.N., Kumar A. and Juyal V., Quantitative Structure Activity Relationship (QSAR) Analysis of Substituted 4-Oxothiazolidines and 5-Arylidines as Lipoxygenase Inhibitors, Mini-Reviews in Medicinal Chemistry 2010; 10 (8) . https://dx.doi.org/10.2174/138955710791572505
DOI https://dx.doi.org/10.2174/138955710791572505 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting of Peptide Cytotoxins to LHRH Receptors For Treatment of Cancer
Current Drug Targets Cardiac Toxicity of Antineoplastic Anthracyclines
Current Medicinal Chemistry - Anti-Cancer Agents Inhibitors of the Microsomal Prostaglandin E2 Synthase-1 as Alternative to Non Steroidal Anti-Inflammatory Drugs (NSAIDs) – A Critical Review
Current Medicinal Chemistry New Chitosan Nanospheres for the Delivery of 5-Fluorouracil: Preparation, Characterization and in vitro Studies
Current Drug Delivery Exosomes and the Emerging Field of Exosome-Based Gene Therapy
Current Gene Therapy Hormone Responsive Breast Cancer and BRCA1 Mutation: Mechanism, Regulation and Iron-mediated Effects
Current Pharmaceutical Biotechnology Triggered Activation and Release of Liposomal Prodrugs and Drugs in Cancer Tissue by Secretory Phospholipase A2
Current Drug Delivery Nanotechnology on Duty in Medical Applications
Current Pharmaceutical Biotechnology Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Modelling and Dosimetry for Alpha-Particle Therapy
Current Radiopharmaceuticals Nutritional Targeting of Cyclooxygenase-2 for Colon Cancer Prevention
Inflammation & Allergy - Drug Targets (Discontinued) Prediction of the Estrogen Receptor Binding Affinity for both hER<sub>α</sub> and hER<sub>β</sub> by QSAR Approaches
Letters in Drug Design & Discovery Mechanism and Inhibition of Matrix Metalloproteinases
Current Medicinal Chemistry Passive Targeting of Cyclophosphamide-Loaded Carbonate Apatite Nanoparticles to Liver Impedes Breast Tumor Growth in a Syngeneic Model
Current Pharmaceutical Design Selected Approaches for Rational Drug Design and High Throughput Screening to Identify Anti-Cancer Molecules
Anti-Cancer Agents in Medicinal Chemistry Prolyl Oligopeptidase: A Rising Star on the Stage of Neuroinflammation Research
CNS & Neurological Disorders - Drug Targets Players in ADP-ribosylation: Readers and Erasers
Current Protein & Peptide Science Pathogenesis of Type 1 Diabetes: Regulation of Adhesion Molecules and Immune Cell Trafficking
Current Immunology Reviews (Discontinued) Modulation of Mitochondrial and Epigenetic Targets by Polyphenols-rich Extract from Araucaria angustifolia in Larynx Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Harnessing the Power of Cerenkov Luminescence Imaging for Gastroenterology: Cerenkov Luminescence Endoscopy
Current Medical Imaging